IL116746A0 - Use of 3, 4-diphenyl chromans for the preparation of pharmaceutical compositions - Google Patents
Use of 3, 4-diphenyl chromans for the preparation of pharmaceutical compositionsInfo
- Publication number
- IL116746A0 IL116746A0 IL11674696A IL11674696A IL116746A0 IL 116746 A0 IL116746 A0 IL 116746A0 IL 11674696 A IL11674696 A IL 11674696A IL 11674696 A IL11674696 A IL 11674696A IL 116746 A0 IL116746 A0 IL 116746A0
- Authority
- IL
- Israel
- Prior art keywords
- preparation
- pharmaceutical compositions
- diphenyl chromans
- chromans
- diphenyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
Applications Claiming Priority (10)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK4795 | 1995-01-13 | ||
| DK4695 | 1995-01-13 | ||
| DK4495 | 1995-01-13 | ||
| DK4895 | 1995-01-13 | ||
| DK4595 | 1995-01-13 | ||
| DK76895 | 1995-06-30 | ||
| DK77295 | 1995-06-30 | ||
| DK76995 | 1995-06-30 | ||
| DK77195 | 1995-06-30 | ||
| DK77095 | 1995-06-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL116746A0 true IL116746A0 (en) | 1996-05-14 |
Family
ID=27579214
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL11674696A IL116746A0 (en) | 1995-01-13 | 1996-01-12 | Use of 3, 4-diphenyl chromans for the preparation of pharmaceutical compositions |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0804190A1 (en) |
| JP (1) | JPH10511962A (en) |
| CN (1) | CN1168096A (en) |
| AU (1) | AU693628B2 (en) |
| CA (1) | CA2208861A1 (en) |
| CZ (1) | CZ212297A3 (en) |
| HU (1) | HUP9702244A3 (en) |
| IL (1) | IL116746A0 (en) |
| MX (1) | MX9705219A (en) |
| NO (1) | NO973243L (en) |
| WO (1) | WO1996021444A1 (en) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5994390A (en) * | 1996-10-28 | 1999-11-30 | Novo Nordisk | Trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
| IL129618A0 (en) * | 1996-10-28 | 2000-02-29 | Novo Nordisk As | Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
| EP0937062B1 (en) * | 1996-10-28 | 2002-12-11 | Novo Nordisk A/S | Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
| AU4700097A (en) * | 1996-10-28 | 1998-05-22 | Novo Nordisk A/S | Novel (cis)-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
| ZA979644B (en) * | 1996-10-28 | 1998-04-28 | Novo Nordisk As | Heterocyclic compounds, compositions and uses. |
| IL129617A0 (en) * | 1996-10-28 | 2000-02-29 | Novo Nordisk As | Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
| DE69718500T2 (en) * | 1996-10-28 | 2003-11-27 | Novo Nordisk As | (-) - ENANTIOMERS OF CIS-3,4-CHROMANE DERIVATIVES FOR THE PREVENTION OR TREATMENT OF OESTROGEN-RELATED DISEASES OR SYNDROMS |
| WO1998018772A1 (en) * | 1996-10-28 | 1998-05-07 | Novo Nordisk A/S | NOVEL cis-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES |
| US6316494B1 (en) | 1996-10-28 | 2001-11-13 | Novo Nordisk A/S | cis3, 4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
| US6043269A (en) * | 1996-10-28 | 2000-03-28 | Novo Nordisk A/S | cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
| US5985306A (en) * | 1996-10-28 | 1999-11-16 | Novo Nordisk A/S | (+)-enantiomers of cis-3,4-chroman derivatives useful in prevention or treatment of estrogen diseases or syndromes |
| JP2001502706A (en) * | 1996-10-28 | 2001-02-27 | ノボ ノルディスク アクティーゼルスカブ | Novel trans-3,4 chroman derivatives useful for prevention or treatment of estrogen-related diseases or syndromes |
| US5958967A (en) * | 1996-10-28 | 1999-09-28 | Novo Nordisk A/S | Cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
| JP2001502708A (en) * | 1996-10-28 | 2001-02-27 | ノボ ノルディスク アクティーゼルスカブ | Novel cis-3,4-chroman derivative useful for prevention or treatment of estrogen-related diseases or syndromes |
| US5919817A (en) * | 1996-10-28 | 1999-07-06 | Novo Nordisk A/S | Cis-3, 4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
| JP4896335B2 (en) * | 2000-03-01 | 2012-03-14 | ナームローゼ・フエンノートチヤツプ・オルガノン | Chroman derivatives as estrogen compounds |
| US8080675B2 (en) | 2004-09-21 | 2011-12-20 | Marshall Edwards, Inc. | Chroman derivatives, medicaments and use in therapy |
| US7601855B2 (en) | 2004-09-21 | 2009-10-13 | Novogen Research Pty Ltd | Substituted chroman derivatives, medicaments and use in therapy |
| EP2635121B1 (en) | 2010-11-01 | 2020-01-08 | MEI Pharma, Inc. | Isoflavonoid compounds and methods for the treatment of cancer |
| KR102395543B1 (en) | 2014-02-07 | 2022-05-09 | 카지아 테라퓨틱스 리미티드 | Functionalised benzopyran compounds and use thereof |
| HUE054998T2 (en) | 2015-02-02 | 2021-10-28 | Mei Pharma Inc | Combination therapies for use in the treatment of breast cancer |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5407955A (en) * | 1994-02-18 | 1995-04-18 | Eli Lilly And Company | Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease |
-
1995
- 1995-01-10 HU HU9702244A patent/HUP9702244A3/en unknown
-
1996
- 1996-01-10 AU AU43293/96A patent/AU693628B2/en not_active Ceased
- 1996-01-10 CN CN96191414A patent/CN1168096A/en active Pending
- 1996-01-10 WO PCT/DK1996/000015 patent/WO1996021444A1/en not_active Application Discontinuation
- 1996-01-10 EP EP96900096A patent/EP0804190A1/en not_active Withdrawn
- 1996-01-10 MX MX9705219A patent/MX9705219A/en unknown
- 1996-01-10 JP JP8521378A patent/JPH10511962A/en active Pending
- 1996-01-10 CA CA002208861A patent/CA2208861A1/en not_active Abandoned
- 1996-01-10 CZ CZ972122A patent/CZ212297A3/en unknown
- 1996-01-12 IL IL11674696A patent/IL116746A0/en unknown
-
1997
- 1997-07-11 NO NO973243A patent/NO973243L/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO973243D0 (en) | 1997-07-11 |
| EP0804190A1 (en) | 1997-11-05 |
| WO1996021444A1 (en) | 1996-07-18 |
| CA2208861A1 (en) | 1996-07-18 |
| HUP9702244A3 (en) | 1999-12-28 |
| AU4329396A (en) | 1996-07-31 |
| NO973243L (en) | 1997-07-11 |
| JPH10511962A (en) | 1998-11-17 |
| AU693628B2 (en) | 1998-07-02 |
| HUP9877967A2 (en) | 1998-12-28 |
| CZ212297A3 (en) | 1997-11-12 |
| MX9705219A (en) | 1997-10-31 |
| CN1168096A (en) | 1997-12-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL116746A0 (en) | Use of 3, 4-diphenyl chromans for the preparation of pharmaceutical compositions | |
| HUP9901159A3 (en) | Substituted benzylaminopiperidine derivatives and use thereof, pharmaceutical compositions containing these compounds | |
| HUP9603495A3 (en) | 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-compounds, pharmaceutical compositions containing the same and process for their preparation | |
| NZ304982A (en) | Pyridinyloxy- or pyridinylamino-acetamide derivatives; pharmaceutical compositions | |
| HUP9901086A3 (en) | Arylsulfonylaminobenzene derivatives, pharmaceutical compositions containing them and their use for producing pharmaceutical compositions | |
| HUP9904046A3 (en) | Novel taxoids, preparation thereof and pharmaceutical compositions containing the same | |
| IL111533A0 (en) | Quinoxalinedione derivatives, methods for the preparation thereof and pharmaceutical compositions containing the same | |
| IL118426A0 (en) | Pharmaceutical composition containing 1,3-bis-triazolyl-2- propanol derivative | |
| ZA967827B (en) | Pharmaceutical compositions | |
| PL322526A1 (en) | Azathiopyrin compositions for intracolic administration | |
| HUP9901485A2 (en) | Heterocyclylcarboxamide derivatives, pharmaceutical compositions containing the same, process for their preparation and their use | |
| HUP9801386A3 (en) | Indazolecarboxamide derivatives, preparation thereof and pharmaceutical compositions containing them | |
| EG24294A (en) | Pharmaceutical compositions | |
| IL116828A0 (en) | Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions | |
| IL116745A0 (en) | Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions | |
| GB9506382D0 (en) | Pharmaceutical compositions | |
| GB9513972D0 (en) | Pharmaceutical compositions | |
| IL116826A0 (en) | Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions | |
| HUP9800631A3 (en) | 4-aminotetrahydrobenzisoxazole or -isothiazole derivatives, pharmaceutical compositions containing them and their use for the preparation of pharmaceutical compositions | |
| IL117806A0 (en) | 1,3-Dihydro-2h-imidazol-2-one derivatives their preparation and pharmaceutical compositions containing them | |
| IL116747A0 (en) | Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions | |
| IL116827A0 (en) | Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions | |
| HUP9900079A3 (en) | 12h-dibenzo[d,g][1,3]dioxocine derivatives, process for their preparation, their use and pharmaceutical compositions containing the same | |
| IL118365A0 (en) | Quinoxalinedione derivatives pharmaceutical compositions containing the same and processes for the preparation thereof | |
| HUP9600061A2 (en) | 3-alkoxycarbonyl-1,3,4-thiadiazin-2-on derivatives, process for their preparation and pharmaceutical compositions containing the same |